Q3 2025 Molina Healthcare Inc Earnings Call Transcript

Oct 23, 2025 / 12:00 PM GMT

Release Date Price: €139.05 (-16.86%)

Transcript 10-Q8-K

Key Points

Positve

Molina Healthcare Inc (MOH) reported a strong Medicaid performance, with a 92% MCR and an adjusted pre-tax margin of 2.6%, despite a challenging medical cost environment.
The company has secured significant new Medicaid contracts in Georgia and Texas, which are expected to contribute to revenue growth in 2026.
Molina Healthcare Inc (MOH) continues to maintain a strong capital foundation, with positive earnings contributing to its capital base and cash flow.
The company has an active pipeline of $54 billion in new opportunities over the next few years, indicating potential for future growth.
Molina Healthcare Inc (MOH) is strategically focused on the dual eligible segment in Medicare, which is poised for significant profitable growth.

Negative

The company's adjusted earnings per share for the third quarter were below expectations, at $1.84, due to a challenging medical cost environment.
Molina Healthcare Inc (MOH) revised its full-year 2025 adjusted earnings per share guidance down to approximately $14, a $5 decrease from prior guidance.
The Marketplace segment significantly underperformed, with a third-quarter MCR of 95.6%, contributing to half of the earnings per share reduction.
The company experienced higher-than-expected medical cost trends across various categories, including behavioral health, pharmacy, and inpatient care.
Molina Healthcare Inc (MOH) anticipates revenue headwinds in 2026 due to repricing in the Marketplace segment, which could impact overall revenue growth.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

MOH.N - Molina Healthcare Inc
Q3 2025 Molina Healthcare Inc Earnings Call
Oct 23, 2025 / 12:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning and welcome to Molina Healthcare's 3rd quarter 2025 earnings call.

All participants will be en listen-only mode should you need assistance, please signal a conference specialist by pressing then 0 on your telephone keypad.

After today's presentation, there will be an opportunity to ask questions, to ask a question you may press star than one on your telephone keypad to withdraw your question, please press star then 2.

Please note this event is being recorded.

I would now like to turn the comforts over to Jeffrey Geier, Vice President, Investor relations at Belina Healthcare.

Please go ahead.

Good morning and welcome to the Molina Healthcare's 3rd quarter, 2025

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.